Navigation Links
Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
Date:9/29/2009

was also President, CEO and Director of "A" Company, a premier brand in the orthodontic appliance market. As with Critikon, Mr. Nye presided over a product line overhaul and eventual sale to Sybron International (now part of Danaher).

Prior to moving into the medical technology industry, Mr. Nye spent nearly 15 years in the consumer packaged goods & leisure business in a variety of marketing, sales and general management roles for companies including Gillette, Olin Ski Company, Reebok and L.A. Gear.

"I am thrilled to join Zeltiq because I can draw from my experience in relevant consumer products and medical technology businesses to propel the company through its commercial phase," said Mr. Nye. "With its advanced cooling technology for fat layer reduction, best-in-class engineering, exceptional talent and superb physician relationships, we hope to position Zeltiq as the most scientifically rigorous and innovative company in the medical aesthetics market."

About Zeltiq Aesthetics

Zeltiq Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The initial Cryolipolysis research and patents were originated at The Wellman Center by Dr. Dieter Manstein and Dr. R. Rox Anderson. Zeltiq has exclusive rights to this innovative new approach to removing fat.

The Zeltiq Procedure is cleared by Health Canada and the European Union for non-invasive fat layer reduction through cold-assisted lipolysis and is available for sale to physicians on a limited basis in the European Union, Canada, the USA, and other select international markets. The Zeltiq device is also cleared by the U.S. FDA for various applications related to skin cooling during dermatologic treatments, with a pending application for non-invasive fat layer reduction. For more information, please visit ww
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
2. California Cryobank Names Richard Jennings President of FamilyCord Division
3. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
4. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
5. Xytis Names Gordon H. Busenbark as Chief Financial Officer
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
8. Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
9. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
10. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
11. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Lyric Pharmaceuticals Inc. today ... round totaling $20.4 million. The financing, co-led by RiverVest ... participation by Aperture Venture Partners. Lyric ... David Wurtman , M.D., M.B.A., President & Chief ... Chief Medical Officer.  In 2014, Lyric closed a seed ...
(Date:2/26/2015)... People with psoriasis and their health ... in research that aims to improve treatments and ... registry begins recruiting patients in 2015. ... Psoriasis Foundation and Corrona, LLC, will initially track ... biologic medication by Novartis Pharmaceuticals for moderate-to-severe psoriasis. ...
(Date:2/26/2015)... , February 26, 2015 ... please scroll to bottom . Investor-Edge has ... (NYSE: JNJ ), Teva Pharmaceutical Industries Ltd ... ENDP ), Allergan Inc. (NYSE: ... ). Free research report on Johnson and Johnson can ...
Breaking Medicine Technology:First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5
... 1 BioMarin Pharmaceutical Inc. (Nasdaq: ... studies on Kuvan (sapropterin dihydrochloride) are being presented ... for The Study of Inborn Errors of Metabolism ... reported that PKU patients taking Kuvan showed improvements ...
... study conducted by oculoplastic surgeon Charles Soparkar, M.D., ... patent-pending formulation of zinc and phytase (trademarked as ... administration for 4 days prior to a planned ... in 41 of 44 patients tested (93%).  Phytase ...
Cached Medicine Technology:Results From Investigator-Sponsored Trials Presented at SSIEM Conference 2Results From Investigator-Sponsored Trials Presented at SSIEM Conference 3Results From Investigator-Sponsored Trials Presented at SSIEM Conference 4Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results 2
(Date:2/27/2015)... 27, 2015 Plugin creators from Pixel Film ... Final Cut Pro X. , “TransFold Volume 3 gives users ... FCPX users.” Said Christina Austin, CEO of Pixel Film ... Cut Pro X editor.” , TransFold Volume 3 comes packed ... The user can decide to change the shadow distance, opacity, ...
(Date:2/26/2015)... (PRWEB) February 27, 2015 2015 Deep ... a professional and in-depth study on the current state ... a focus on the Chinese situation. , Major companies ... SHANGDONG ZOUPING, Hualun, Jiangsu Yuanyang, ZHENGZHOU TONGLI, Hebei ... and Jain & Jain. , The report provides a ...
(Date:2/26/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... says contains absolute proof that the bible can be trusted ... the plan, or purpose for mankind is. He says a ... beginning and an end. , “Yahweh has allotted 6,000 ... walk in His Righteousness, and who will not. Those who ...
(Date:2/26/2015)... Marking its fifth successful year of business, UV ... the development of a new and improved UV-Aid light supplement ... spring. UV-Aid is a unique and patent pending technology that ... areas of the body susceptible to infection. UVA light has ... daily dose of UV-Aid is equivalent to less than a ...
(Date:2/26/2015)... 2015 Healthpointe is proud to ... Dr. Neil Thomas Katz, MD, is now offering ... throughout Southern California, including Long Beach , ... and fellowship-trained to provide quality care, and specializes ... Neil Katz provides surgical and non-surgical treatments for ...
Breaking Medicine News(10 mins):Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:World Benzoyl Peroxide Market Forecast Report 2015-2020 Now at Available DeepResearchReports.com 2Health News:World Benzoyl Peroxide Market Forecast Report 2015-2020 Now at Available DeepResearchReports.com 3Health News:Yisrayl Hawkins Says There is Only One Place Shown in Scripture to Achieve Salvation and Shows Proof in New Letter 2Health News:UV Technologies, LLC Developing New More Effective UV-Aid for Flu and Cold Prevention 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 3
... found that Salmonella bacteria found in garden birds are ... the bacteria found in livestock and humans. , Salmonella ... undetected in animals, which increases the risk of the ... strains found in birds in the laboratory and found ...
... of NSCLC, CHICAGO, June 2 Exelixis, Inc. ... of XL647, a novel small molecule,inhibitor of EGFR, HER2, ... Society of Clinical Oncology (ASCO). Updated data from an ... cell,lung cancer (NSCLC) patients show encouraging anti-tumor activity of ...
... NEW YORK, June 2 American Oriental,Bioengineering (NYSE: ... of Directors has,authorized a share repurchase program for ... Company,s outstanding common stock., Purchases under this ... in the,open market, privately negotiated transactions, and accelerated ...
... Pain Patients with Substance ... Use Disorders WHO: ... 4th - 6th, ... pm, PHILADELPHIA, June 2 Valley Forge Medical Center and,Hospital is the first facility on ...
... with a combination of chemotherapy, biotherapy and radiotherapy prior ... patients, according to a University of Pittsburgh Cancer Institute ... the American Society of Clinical Oncology (ASCO) in Chicago. ... Cancer Center of the University of Pittsburgh Medical Center ...
... CO June 2, 2008 Results from an ... and lost time among employees suffering from multiple sclerosis ... were presented and announced by Biogen Idec as poster ... annual meeting in Denver, Colorado, May 28-May 31, 2008. ...
Cached Medicine News:Health News:Salmonella in garden birds responsive to antibiotics 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 3Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 4Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 5Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 6Health News:American Oriental Bioengineering Announces US$75 Million Share Repurchase Program 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 3Health News:New treatment combination safe for pancreatic cancer patients 2Health News:New data show patients using avonex reported less sick leave and short-term disability costs 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: